PANCREATIC CANCER ACTION NETWORK ADAPTIVE CLINICAL TRIAL ADDS NEW INVESTIGATIONAL TREATMENT AND ADDITIONAL SITES
Investigational Treatment From Novartis To Be Activated At Precision PromiseSM Clinical Trial Sites Across the Country, Including Five Additional Premier Cancer Institutions LOS ANGELES, March 24, 2022 /PRNewswire/ — The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, has announced the latest updates to its innovative adaptive clinical trial, Precision PromiseSM, including the addition of […]